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ABSTRACT
Framingham Risk Scores is an established method to predict an individual’s 10-
year risk for coronary heart disease (CHD).  It provides a more precise delineation
of risk which might lead to appropriate selection of therapy and opportunities for
patient education and motivation.  A Healthy Lifestyle Project was initiated to
decrease the modifiable risk factors for CHD in a worksite in Kuala Lumpur.  The
participants were Malay men (n=186) working as security guards in a public
university.  Their mean age was 46.6 + 6.6 years.  The majority had secondary
education and were married.  The participants’ 10-year risks based on the
Framingham Risk Scores were 55.4%, 39.8% and 4.8% respectively for categories
of low (< 10%), intermediate (10 to 20%) and high (>20%) risk.  Their Framingham
Risk Scores were then correlated with anthropometric measurements such as the
Body Mass Index (BMI), waist circumference and waist-hip-ratio (WHR).  All the
anthropometric measurements had weak but significant correlation with the
Framingham Risk Scores (WHR: r=0.26; waist circumference: r=0.23; BMI: r=0.16).
In conclusion, 44.6% of our participants had more than 10% risk in developing
CHD in the coming ten years.  Hence, they are suitable target candidates for the
promotion of a healthy lifestyle such as smoking cessation, weight control, healthy
dietary patterns and increased physical activities.  Indicators of abdominal obesity
like WHR or waist circumference may be used to complement the Framingham
Risk Scores for the prediction of CHD risk in this population.
INTRODUCTION
Malaysia has developed from an agriculture-
based economy to one that emphasises
manufacturing.   The nation’s health status
has also improved significantly with infant
mortality rate decreasing from 19.7 per 1000
live births in 1981 to 6.6 per 1000 live births
in 2006, while the life expectancy of males
and females in the same year was 71.8 and
76.3 years respectively (Statistics
Department, 2006).  These improvements
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may be attributed to socio-economic growth
and better health services.  Similarly, the
disease pattern has also shifted from
communicable to non-communicable
diseases.
In 2006, heart disease  and  diseases of
pulmonary circulation were the second
leading cause of death in the Ministry of
Health hospitals in Malaysia, while
diseases of the circulatory system were the
fourth leading cause of hospitalisation in
the same year (MOH,  2006).  Cardiovascular
disease (CVD) was also the leading cause of
medically certified and inspected deaths in
the same year (Statistics Department,  2006).
It is a matter of concern that people may
not be aware of their personal risk to CVD.
Therefore it is crucial that the adult
population be screened periodically for
cardiovascular risks.  Screening of lipid
profile can be used alone to determine the
risk of CVD and need for treatment or it can
be combined with information on  other risk
factors.  However, strategies that explicitly
consider a person’s other coronary heart
disease (CHD) risk factors in addition to the
lipid profile are more accurate than those
that measure only lipid profiles (Wilson et
al., 1998).  Grover, Coupal & Hu (1995) found
that a Framingham-based coronary risk
model was the best predictor of CHD
mortality as this  model helped to define the
quantitative and additive nature of
cardiovascular risk factors.  These
cardiovascular risk factors included
cigarette smoking, hypertension, high serum
cholesterol and various cholesterol fractions,
low levels of high density lipoprotein (HDL)
cholesterol and advancing age (Grover et al.,
1995).
Framingham Risk Scores emanating
from the above model provide a realistic
picture of an individual’s 10-year
cardiovascular risks.  It is helpful in tailoring
a plan for risk factor management,
particularly in primary prevention to modify
risk factors or prevent their development.
This will delay or prevent new-onset of CHD.
These scores provide a more precise
delineation of absolute risk, which might
lead to a more precise selection of
appropriate therapy as well as patient
education and motivation.  While patients
with low risk scores can be reassured, those
with higher scores should be counselled to
adopt risk-reducing lifestyle habits (such as
smoking cessation, dietary change, weight
control and exercise).
In a Healthy Lifestyle Project initiated
in Kuala Lumpur, participants’ cardio-
vascular risks were assessed using the
Framingham Risk Scores.  Anthropometric
measurements such as body mass index
(BMI), waist circumference and waist hip
ratio (WHR) were also used to evaluate their
relationship with the Framingham Risk
Scores.
MATERIALS AND METHODS
This project involved a cross-sectional
survey on security guards working in the
campus and the hospital of a public
university in Kuala Lumpur.  Approval was
obtained from the Medical Ethics Committee
of the university and the management of both
the security units.  All security guards
(n=210) were invited to participate and
informed consent was obtained from all
respondents.  The majority of the security
staff were men and of Malay ethnicity (>95%);
women and participants of other ethnicity
groups  were excluded from the analysis.
Anthropometric measurements which
included weight, height, waist and hip
circumferences were taken.  Height was
taken to the nearest 0.1cm using the
microtoise which was mounted to the wall;
subjects were asked to remove their shoes
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before measurement was taken.  Weight was
taken using the SECA digital scale and the
machine was calibrated regularly with
known weight.  Weight was measured to the
nearest 0.1kg with shoes, hand phone, coins
and wallets removed.  Waist and hip
circumferences were taken following the
WHO (1995) procedure.  Both measurements
were taken to the nearest 0.1cm.   Body mass
index (BMI) was calculated using the
formula of weight (kg) divided by height2
(m2).  Waist hip ratio (WHR) was calculated
by dividing waist circumference with hip
circumference.
Clinical and biochemical indicators,
which included blood pressure, fasting
blood glucose and full lipid profile (i.e. total
cholesterol, HDL-cholesterol, LDL-
cholesterol and triglycerides) were
determined.  Blood pressure was measured
using a digital automatic blood pressure
monitor (Omron HEM – 907 model).  The
subjects were required to be seated while two
measurements were taken using the
subject’s left arm with a one-minute interval;
the mean was recorded.
Venous blood was drawn for screening
of full lipid profile and fasting blood glucose.
Each subject was required to fast for at least
8 – 10 hours prior to drawing blood. Fasting
blood glucose was measured using the
advantage blood glucose monitor on the
spot.  Total cholesterol, HDL cholesterol and
triglycerides were analysed using the
Dimension ® clinical chemistry system (an
in-vitro diagnostic test); while the LDL-
cholesterol was calculated using the
Friedewald formula (Friedewald, Levy &
Fredrickson 1972).
Socio-demographic data, medical
history, family history of CVD and lifestyle
practices of the participants were collected
through a set of pre-tested self-administered
questionnaire.  The questionnaire was in the
Malay language.
The Framingham Risk Scores (FRS)
was computed based on the National
Cholesterol Education Program (NCEP)
Adult Treatment Panel (ATP) III procedures
(NCEP, 2002).  The participants’
cardiovascular risk was assessed via a 2-
step procedure.  First, the participants’ major
risk factors for CVD (such as smoking,
hypertension with blood pressure >140/90
mmHg or on treatment, males aged 45 years
and above, with a family history of CHD and
low HDL-cholesterol which was less than
1.01mmol/l) were counted.  Their 10-year
CHD risk was calculated using the
Framingham scoring which was based on
age, total cholesterol, HDL-cholesterol, blood
pressure and cigarette smoking.
Framingham scoring categorises persons
with multiple risk factors into those with 10-
year risk for CHD of >20% (high risk), 10 to
20% (moderate risk) and <10% (low risk).
All data was entered and analysed
using the SPSS for Windows version 11.0.
Data was cleaned and checked for
discrepancies before analysis.  Pearson
correlation was used to correlate two
quantitative variables.  Significance level
was preset at 0.05.
RESULTS
A total of 186 subjects participated, giving a
response rate of 88.6%.  Table 1 shows the
socio-demographic and clinical charac-
teristics of the participants.  The participants
had a mean age of 46.6 + 6.6 years and the
majority were married with secondary
education.   Self-reported diseases such as
diabetes mellitus, hypertension and
coronary heart disease (CHD) as well as their
family history of premature CHD are shown
in Table 1.
Participants’ anthropometric measure-
ments are shown in Table 2.   Their mean
BMI was 26.36 + 3.63 kg/m2 while the
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Table 1. Socio-demographic and clinical characteristics of participants
   n (%)
Education : No formal education     3 (1.6)
Primary   2 (12.4)
Secondary 160 (86.0)
Marital status Single/ divorced   13 (7.0)
Married 173 (93.0)
Family history of CHD 23 (12.4)
Medical history: Diabetes 36 (19.4)
Hypertension 37 (19.9)
CHD   4 (2.2)
Age (years)  (mean + s.d.) 46.6 + 6.6
Table 2. Participants’ anthropometric measurements
Mean + s.d.
Height (cm) 167.5 + 5.1
Weight (kg) 74.0 + 11.2
Waist circumference (cm) 91.5 + 9.1
Hip circumference (cm) 101.6 + 7.1
BMI (kg/m2) 26.36 + 3.63
WHR 0.90 + 0.05
Table 3. Proportion of participants with cardiovascular risk factors
Risk factor n (%)
Cigarette smoking 70 (37.6)
Hypertension 59 (31.7)
Low HDL cholesterol 65 (34.9)
Family history of premature CHD 23 (12.4)
Age (> 45 years) 110 (59.1)
Table 4. Correlation of Framingham Risk Scores to anthropometric
measurements
Pearson correlation p
coefficient, r
BMI 0.163 0.026
Waist circumference 0.233 0.001
WHR 0.257 <0.001
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Figure 1. CVD risk factors among the participants
abdominal obesity indicators such as waist
circumference and WHR were 91.5 + 9.1cm
and 0.90 + 0.05 respectively.
Cardiovascular risk factors such as
cigarette smoking, hypertension (blood
pressure more than 140/90 mmHg or on
medication for hypertension), low HDL
cholesterol (<1.01 mmol/l),  a family history
of premature CHD and number of those aged
45 years  and more are reported in Table 3.
Approximately 60% of the participants were
aged more than 45 years and about one-third
of them were smokers, had hypertension and
low HDL-cholesterol.
When the above risk factors were
calculated for each participant, it was found
that approximately 60% of them had two or
more of the above risk factors (Figure 1).  The
Framingham Risk Scores showed that about
55% had low risk (<10%), 40% moderate risk
(10 to 20%) while 5% would be exposed to
high risk (>20%) in the next  10 years.
When the Framingham Risk Scores
were correlated with BMI, waist
circumference and WHR, the following
results were obtained (Table 4).  All the
measurements had significant but weak
correlation with Framingham Risk Scores.
DISCUSSION
This cross-sectional questionnaire survey
shows that 45% of the participants had
moderate to high 10-year risk for CHD using
the Framingham risk scoring.   The
Framingham risk scoring system considers
an individual’s other CHD risk factors in
addition to the lipid profile.  It predicts more
accurately for CHD mortality (Wilson et al.,
1998).   The 10-year risk categories for CHD
provide opportunities for primary
prevention of CHD.  This could be carried
out through patient education and
motivation.
Appropriate prediction of CHD risk is
crucial in patient education and motivation.
Periodic monitoring is needed to assess
whether the  risk status has changed.  Low
absolute risk particularly among young
adults does not ensure a lifetime of low risk
because the number and severity of metabolic
risk factors worsen with aging.  Therefore,
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the risk reduction message should also be
conveyed to low-risk persons in the general
population.  Any single risk factor if
untreated for long periods can produce major
cardiovascular events.  For example, years
of cigarette smoking predisposes to lung
cancer and atherosclerotic cardiovascular
disease (Eliasson et al., 2001; Rylander and
Axelsson, 2006), while untreated
hypertension can cause stroke, CHD and
renal failure (Cuddy, 2005;  Staessen et al.,
2005;  Walsh et al., 2006).
Anthropometric measurements such as
BMI, waist circumference and WHR are
easily measured and monitored.  The
significant correlation observed between
these measurements with Framingham Risk
Scores provides additional indicators for
identifying individuals at increased CVD
risks.  In this survey, BMI had the lowest
correlation with FRS, while WHR had the
strongest with the Framingham Risk Scores
for CVD.    Similar results were demonstrated
by Esmaillzadeh, Mirmiran & Azizi (2004)
among Tehranian adult men and Megnien
et al (1999) among the French population.
However, different results were found for
females (Mosca et al., 2006; Esmaillzadeh,
Mirmiran & Azizi, 2006) and males of other
ethnic groups (Smith, Ness & Herbert, 2005).
In the studies carried out by Mosca et al.
(2006) and Esmaillzadeh et al. (2006), waist
circumference performed better than WHR
among the females in predicting CVD risk;
Smith et al (2005) found that waist
circumference was a better predictor among
Caucasian males.  A study with a bigger
sample size of both Malay males and females
should be undertaken for further analysis of
the above.
Although FRS is a valuable tool in
predicting CHD risk, it has some limitations.
The scoring system was derived from the
Framingham Heart Study of participants
that differed in geographic and ethnic
groups from our local scenario.  Furthermore,
the FRS did not take into account all known
risk factors for CHD such as obesity, levels
of triglyceride, homocysteine etc.   However,
an advantages of using FRS is that it
suggests priorities for instituting primary
prevention strategies and identifies factors
deserving increased emphasis and those
needing less attention.   It also stipulates that
the healthcare professionals need to look at
the patient as a whole and to recognise the
cumulative nature of risk factors.  This
multifactorial approach to risk reduction
offers the best opportunity for saving patients
at high risk and preventing development of
high risk status in the first place.
CONCLUSION & RECOMMENDATIONS
In conclusion, the simple assessment of
waist and hip circumferences may be an
additional and valuable tool to predict CVD
risk alongside the Framingham Risk Scores
of Malay males.  Malaysian CHD predictors
should be developed by following up
multiracial cohorts since different ethnic
groups might have different risk factors.
Evaluation of indicators on adiposity (waist
circumference and WHR) should also be
carried out on larger cohorts
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